Search

Searching with a thematic focus on Agriculture and food, Biotechnology and GMOs, Biotechnology and GMOs governance

Showing 121-130 of 145 results

Pages

• Document

  Intellectual property rights, biotechnology and food security

  Institute of Development Studies UK, 2003

  This paper examines the relationship between food security, agricultural biotechnology and intellectual property rights (IPRs), particularly for developing countries and poorer groups within those countries.Main findings include:for low income developing countries, the costs of strengthening IPRs may well outweigh the gainspro-IPR industry representatives and trade officials, with p
• Document

  Rights and risk: challenging biotechnology policy in Zimbabwe

  Environment Team, IDS Sussex, 2003

  This paper looks at how a rights based approach can be applied to biotechnology policy. Drawing on the experience of Zimbabwe and other countries in southern Africa, this paper argues that a risk based approach to biotechnology regulation creates an artificial divide between civil and political rights and economic, social and cultural rights.
• Document

  Contexts for regulation: GMOs in Zimbabwe

  Environment Team, IDS Sussex, 2003

  This paper looks at the regulation of biotechnology in Zimbabwe.
• Document

  Biotech firms, biotech politics: negotiating GMOs in India

  Environment Team, IDS Sussex, 2003

  This paper explores the different corporate strategies of firms in the biotech and seed sectors and looks at how they have organised themselves to influence the policy process.The paper suggests the importance of looking at divisions within capital and the political alliances that firms form as a basis for understanding the ways in which policy choices are framed and decisions taken.
• Document

  Seeds in a globalised world: agricultural biotechnology in Zimbabwe

  Environment Team, IDS Sussex, 2003

  This paper looks at what biotechnology might mean for agricultural and food production systems in Zimbabwe and looks at some of the strategic questions that lie behind decisions to go the GM route in agriculture.Several factors are identified and discussed including:technology choiceissues of technology access and ownershipthe role of new farmers emerging as a result of land ref
• Document

  Regulating biotechnology in China: the politics of biosafety

  Institute of Development Studies UK, 2003

  This paper examines the politics of biosafety regulation in China and policy processes around Genetically Modified (GM) crops.The paper:locates biosafety debates in wider contexts, both in terms of what is happening in China in biotechnology, and in terms of the global politics of biosafety.
• Document

  Bt cotton benefits, costs and impacts in China

  Institute of Development Studies UK, 2003

  This paper provides a follow up study, 2000/1, of the effect of Bt cotton adoption in China, 1999.Main findings include:the production Bt cotton has positive crop yield impacts, shifting the crop yield frontier by nearly 10 percentBt cotton farmers increased their incomes by reducing use of pesticides and labour inputsBt cotton continues to have positive environmental and health
• Document

  Biotechnology policy and regulation in China

  Institute of Development Studies UK, 2003

  This paper refutes claims that China has in recent years fundamentally altered its stance on GMOs in response to trade, food safety and environmental biosafety concerns.
• Document

  The biotech developmental state?: investigating the Chinese gene revolution

  Institute of Development Studies UK, 2003

  This paper looks at how and why China has pursued research on agricultural biotechnology within the public sector, in contrast with other parts of the world where the private sector has been dominant. In particular, the paper focuses on the role of science-policy networks in promoting a biotechnology discourse.
• Document

  Business and biotechnology: regulation and the politics of influence

  Institute of Development Studies UK, 2003

  This paper explores the issue of regulation of biotechnology products at the national and international level, paying special attention to the role of biotechnology firms and the responses of civil society groups.It argues that the private biotechnology sector, thanks to its level of expertise and the amount of capital it owns, is a key adviser and a powerful player in the politics of biotechno

Pages